| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-11 13:43:51 UTC |
|---|
| Updated at | 2024-09-11 13:43:51 UTC |
|---|
| NP-MRD ID | NP0338076 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Rhapontin |
|---|
| Description | Rhapontin was first documented in 2020 (PMID: 35520676). Based on a literature review a small amount of articles have been published on Rhapontin (PMID: 34254908) (PMID: 38919748) (PMID: 37295190) (PMID: 38757037). |
|---|
| Structure | COC1=CC=C(\C=C/C2=CC(OC3OC(CO)C(O)C(O)C3O)=CC(O)=C2)C=C1O InChI=1/C21H24O9/c1-28-16-5-4-11(8-15(16)24)2-3-12-6-13(23)9-14(7-12)29-21-20(27)19(26)18(25)17(10-22)30-21/h2-9,17-27H,10H2,1H3/b3-2- |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C21H24O9 |
|---|
| Average Mass | 420.4140 Da |
|---|
| Monoisotopic Mass | 420.14203 Da |
|---|
| IUPAC Name | 2-{3-hydroxy-5-[(1Z)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol |
|---|
| Traditional Name | 2-{3-hydroxy-5-[(1Z)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=CC=C(\C=C/C2=CC(OC3OC(CO)C(O)C(O)C3O)=CC(O)=C2)C=C1O |
|---|
| InChI Identifier | InChI=1/C21H24O9/c1-28-16-5-4-11(8-15(16)24)2-3-12-6-13(23)9-14(7-12)29-21-20(27)19(26)18(25)17(10-22)30-21/h2-9,17-27H,10H2,1H3/b3-2- |
|---|
| InChI Key | GKAJCVFOJGXVIA-IHWYPQMZNA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Classification | Not classified |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| External Links |
|---|
| HMDB ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FoodDB ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | Not Available |
|---|
| KEGG Compound ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Rhaponticin |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | Not Available |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| General References | - Ouyang X, Li X, Liu J, Liu Y, Xie Y, Du Z, Xie H, Chen B, Lu W, Chen D: Structure-activity relationship and mechanism of four monostilbenes with respect to ferroptosis inhibition. RSC Adv. 2020 Aug 21;10(52):31171-31179. doi: 10.1039/d0ra04896h. eCollection 2020 Aug 21. [PubMed:35520676 ]
- Rehman A, Ashfaq UA, Javed MR, Shahid F, Noor F, Aslam S: The Screening of Phytochemicals Against NS5 Polymerase to Treat Zika Virus Infection: Integrated Computational Based Approach. Comb Chem High Throughput Screen. 2022;25(4):738-751. doi: 10.2174/1386207324666210712091920. [PubMed:34254908 ]
- Zeng Q, Hu H, Huang Z, Guo A, Lu S, Tong W, Zhang Z, Shen T: Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment. Front Mol Biosci. 2024 Jun 11;11:1413214. doi: 10.3389/fmolb.2024.1413214. eCollection 2024. [PubMed:38919748 ]
- Liu L, Liu H, Yan H, Guo H, Bai L: Separation and purification of glycosides from medicinal plants based on strong polar separation medium with online closed-loop mode. J Pharm Biomed Anal. 2023 Sep 20;234:115508. doi: 10.1016/j.jpba.2023.115508. Epub 2023 Jun 7. [PubMed:37295190 ]
- AlAjmi MF, Azhar A, Hasan S, Alshabr AZ, Hussain A, Rehman MT: Identification of natural compounds (proanthocyanidin and rhapontin) as high-affinity inhibitors of SARS-CoV-2 Mpro and PLpro using computational strategies. Arch Med Sci. 2021 Mar 20;20(2):567-581. doi: 10.5114/aoms/133706. eCollection 2024. [PubMed:38757037 ]
|
|---|